News » AIDS

1 thru 10 of 780 Stories

On National Black HIV/AIDS Awareness Day, We're Our Brothers' Keeper

Feb 5
The 16th annual National Black HIV/AIDS Awareness Day (NBHAAD) is being observed on Saturday, February 7. As has been the case for the past several years, the theme for NBHAAD in 2015 is: "I Am My Brother's/Sister's Keeper: FIGHT HIV/AIDS!"

HIV Infection Higher Among Blacks and Latinos for Decades

Feb 4
Compared to whites, the rate of new HIV infection is about eight times higher among Blacks and about three times higher among Hispanics.

Transgender Vets Suffer Higher Rates of Mental and Medical Health Issues

Feb 3
A research team led by George Brown of Mountain Home Veterans Affairs Medical Center has found that transgender patients have more psychiatric and medical health outcome disparities.

Gilead Faces Legal Action Over Hep C Drug Price Gouging

By EDGE | Feb 2
Amidst allegations of price gouging, Massachusetts Attorney General Maura Healey has promised to take legal action against Gilead if it doesn't cut the price of its antiviral hepatitis C and HIV meds Sovaldi and Harvoni.

With FDA Approval, PRO 140 Could Make HAART A Weekly Injection

By EDGE | Feb 2
After decades of taking multiple pills day-in and day-out, the HIV infected could finally take a break, substituting injections for pills.

Harvey Weinstein To Be Honored at amfAR's Annual Fashion Week NY Gala

By EDGE | Feb 1
On Feb. 10, amfAR will honorlegendary Academy Award-winning film producer and longtime amfAR supporter and friend, Harvey Weinstein, for his exceptional contributions to the global struggle against HIV/AIDS.

GOP Presidential Candidates Snub GMHC's Survey on Ending HIV and AIDS

Jan 28
If you're looking for an end to HIV/AIDS, don't think you'll get any answers from the current crop of GOP presidential hopefuls.

AHF Files Federal Lawsuit Against Gilead to Invalidate Patents on Key AIDS Drug  

Jan 27
On Jan. 26, the AHF filed a federal lawsuit against Gilead Sciences Inc., whom they believe is trying to monopolize the market through price gouging on HIV/AIDS drugs.

The Elton John AIDS Foundation Awards More Than $5.4 Million in New Grants

By EDGE | Jan 27
The Elton John AIDS Foundation announced a new series of grants totaling more than $5.4 million to support organizations addressing the HIV/AIDS epidemic in critical and innovative ways.

CytoDyn HIV Patients Report 17 Months of Viral Suppression

By EDGE | Jan 27
CytoDyn Inc. announced that its ongoing extension study of PRO 140 monotherapy in a cohort of HIV-infected patients has shown complete viral-load suppression for well over a year with some patients approaching 17 months.

1 thru 10 of 780 Stories